Cylene Pharmaceuticals
San Diego
About Cylene Pharmaceuticals
Cylene Pharmaceuticals is a biotech pharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs that target the nucleolus and kill cancer cells. It offers nucleolus-targeting agents, which are small-molecule targeted cancer therapeutic agents for carcinoid/neuroendocrine tumors and pediatric brain tumors, and serine/threonine protein kinase inhibitors. The company also provides preclinical-stage oral drug candidates. Cylene Pharmaceuticals was founded in 1997 as Cyternex, Inc., and changed its name to Cylene Pharmaceuticals in October 2003. The company is based in San Diego, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $102.3M
- Funding stage: Late Stage Venture
- Last round: Debt Financing (Jan 2013)
- Website: cylenepharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cylene-pharmaceuticals-2859608 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.